Video
LUGPA 2021: Dr. Chad Ellimoottil on telemedicine
Author(s):
“Telehealth really helped salvage some of the care that was deferred during the early part of the pandemic, and it’s really here to stay,” says Chad Ellimoottil, MD, MS.
Video Player is loading.
In this video from the 2021 LUGPA annual meeting, Chad Ellimoottil, MD, MS, discusses the COVID-19 pandemic’s impact on telemedicine uptake among urologists as well as how he prepares differently for a telemedicine vs an in-person appointment. Ellimoottil is Assistant Professor of Urology and Director of the University of Michigan’s Telehealth Research Incubator.
Related Videos
5 key trial insights from AUA 2025
Shreyas Joshi, MD, recaps AUA session on chemotherapy vs novel NMIBC options
Shay Rajavel, MS3, on CO2 gas embolism during single-port partial nephrectomy
Kevin Zorn, MD, on preserving ejaculation with BPH therapies
Neal Shore, MD, on sasanlimab plus BCG for BCG-naïve NMIBC
Alexander Glaser, MD, on real-world outcomes with Aquablation
Vitaly Margulis, MD, on preliminary safety, efficacy of padeliporfin VTP for UTUC
Joseph Jacob, MD, on the durability of TAR-200 in NMIBC
Margaret Knoedler, MD, on Ho:YAG vs thulium fiber laser for ureteroscopy
John Gore, MD, on radical cystectomy vs bladder-sparing therapy for NMIBC
Related Content
